Dentists in Creedmoor, NC Accepting Medicare
4 Dentists found. Showing 1 - 4
 Dr. Kenneth Reid Marsh, DDS Dentist Medicare: Medicare Enrolled Practice Location: 1582 Hwy 56, Creedmoor, NC 27522 Phone: 919-528-1980 Fax: 919-528-8610 |
Dr. Aaron Scott Hewett, DMD Dentist Medicare: Not Enrolled in Medicare Practice Location: 110 W Church St, Creedmoor, NC 27522 Phone: 919-528-4004 Fax: 919-528-2594 |
Dr. Matthew Henrichsen Willis, D.D.S Dentist - General Practice Medicare: Medicare Enrolled Practice Location: 110 W Church St, Creedmoor, NC 27522 Phone: 919-528-4004 Fax: 919-528-2211 |
Dr. Herbert Bennett Edgerton, DDS Dentist - General Practice Medicare: Medicare Enrolled Practice Location: 1582 Hwy 56, Creedmoor, NC 27615 Phone: 919-528-1980 |
News Archive
Seattle Children's opens enrollment for first clinical trial of Tumor Paint BLZ-100 for children with brain tumors
Seattle Children's today announced the opening of patient enrollment for the first clinical research trial of the drug Tumor Paint BLZ-100, which is designed to improve surgical outcomes in children with brain tumors – the most common solid tumor cancer in kids.
InDevR's new VaxArray to improve potency testing for measles and rubella vaccines
InDevR announced today that it will pursue proof of concept development for new VaxArray potency assays for measles and rubella vaccines sponsored by the Bill & Melinda Gates Foundation.
Bodily illusions rearrange the sense of touch
The brain is bombarded by information about the physical proportions of our bodies. The most familiar sensations, such as a puff of wind or the brush of our own shirt sleeve, serve to constantly remind the brain of the body's outer bounds, creating a sense of what is known as proprioception.
LFB Biotechnologies exercises its option to purchase $12.8 million of stocks in GTC Biotherapeutics
GTC Biotherapeutics, Inc. announced that LFB Biotechnologies, a wholly owned subsidiary of LFB S.A. (Laboratoire français du Fractionnement et des Biotechnologies S.A., Les Ulis, France) and a strategic shareholder in GTC, has exercised its option to purchase $12.8 million of additional convertible preferred stock under the terms described in the financing agreements approved by GTC shareholders in July 2009. This transaction provides $6.4 million of new cash proceeds to GTC.
Hormone therapy findings suggest a complex relationship between marketing, scientific evidence and prescribing patterns
Pharmaceutical companies slashed their promotional spending for hormone therapies by more than a third following reports in July 2002 of health risks associated with the drugs, but within the year they beefed up their marketing efforts to promote lower-dose forms of the medications
› Verified 1 days ago
Counselors
Pharmacists
Clinical Social Workers
Dentists
Psychologists
Occupational Therapists